Ioneer
IONR
6 hedge funds and large institutions have $606K invested in Ioneer in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
50% more funds holding
Funds holding: 4 → 6 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
19% less capital invested
Capital invested by funds: $750K → $606K (-$144K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$108K |
| 2 |
CSPIA
Cary Street Partners Investment Advisory
Richmond,
Virginia
|
+$29.3K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$28.3K |
| 4 |
US Bancorp
Minneapolis,
Minnesota
|
+$621 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.21K |
| 2 |
Morgan Stanley
New York
|
-$2K |
IONR Hedge Fund Activity: Q4 2022 in Review
6 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Ioneer (IONR) for Q4 2022, worth a combined $606K — down 19% from $750K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IONR positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Royal Bank of Canada, opening a new position worth an estimated $108K. The largest seller was Tower Research Capital (TRC), cutting an estimated $2.21K.
- 6 institutional investors held Ioneer (IONR) as of Q4 2022, up from 4 in Q3 2022.
- Funds reported $606K of Ioneer stock for Q4 2022, down 19% quarter-over-quarter.
- 3 funds opened new Ioneer positions in Q4 2022 and 1 closed out, a net change of +2 holders.
- The largest Ioneer buyer in Q4 2022 was Royal Bank of Canada, an estimated $108K added.
- The largest Ioneer seller in Q4 2022 was Tower Research Capital (TRC), an estimated $2.21K sold.
Based on aggregated 13F filings for Q4 2022.